Probiotec (ASX:PBP)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Probiotec.
RELATED STOCKHEAD STORIES
2024: All the latest broker moves
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
ASX Escrow Watch: Which lithium plays are releasing shares heading into 2023?
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Director Trades: Which telco director got a $9 million+ pay day?
ASX Health Stocks: Results show revenue is growing in first half, but profitability still elusive
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
Market Highlights and 5 ASX Small Caps to watch on Wednesday
